Clinical and Biological Evaluation of the Novel Cd30/Cd16a Tetravalent Bispecific Antibody (Afm13) in Relapsed or Refractory Cd30-Positive Lymphoma With Cutaneous Presentation: A Biomarker Phase Ib/Iia Study (Nct03192202)
Hematological Oncology - United Kingdom
doi 10.1002/hon.123_2630
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2019
Authors
Publisher
Wiley